PharmaCyte Biotech, Inc. Consulting Agreements
6 Contracts & Agreements
- Separation, Consulting and Release Agreement, dated October 6, 2022, by and between PharmaCyte Biotech, Inc. and Kenneth L. Waggoner (Filed With SEC on October 7, 2022)
- Consulting Agreement (Filed With SEC on October 3, 2014)
- Consulting Agreement (Filed With SEC on October 3, 2014)
- Consulting Agreement (Filed With SEC on October 3, 2014)
- MASTER CONSULTANCY AGREEMENT Between Nuvilex, Inc. And BB Biotech Consulting GmbH (Filed With SEC on August 4, 2014)
- CONSULTING AGREEMENT (Filed With SEC on August 4, 2014)
